TL;DR
A compound found in rice bran, ferulic acid, has been shown in laboratory studies to reduce intestinal muscle contractions by blocking calcium channels. This discovery could lead to new dietary approaches for managing gut motility disorders like IBS, though human trials are needed to confirm efficacy.
New laboratory research from Toho University demonstrates that ferulic acid, a compound naturally occurring in rice bran, can significantly reduce intestinal smooth muscle contractions by blocking voltage-dependent calcium channels. This finding suggests potential dietary or supplement-based strategies for managing gut motility disorders such as irritable bowel syndrome (IBS). However, effects in humans remain unconfirmed, and further studies are required.
The study, led by researchers at Toho University, tested ferulic acid (FA) on guinea pig intestinal smooth muscle tissues. The results showed that FA decreased contractions triggered by various signaling molecules, including acetylcholine and serotonin, in a reversible and concentration-dependent manner. This indicates that FA interferes with muscle contraction mechanisms rather than receptor activity.
Additional experiments with vascular smooth muscle cells revealed that FA inhibits calcium influx into cells by blocking voltage-dependent calcium channels. Since calcium entry is essential for muscle contraction, this suggests a mechanism by which FA may regulate intestinal motility.
While the findings are promising, the concentrations of FA used in the experiments exceeded typical dietary levels, raising questions about the practical applicability in humans. Researchers note that intestinal contact with FA after food consumption may produce higher localized concentrations, but clinical trials are necessary to determine safety, effective dosage, and actual benefits for patients with conditions like IBS or IBD.
Implications for Treating Gut Motility Disorders
This discovery highlights the potential of ferulic acid as a natural agent to modulate intestinal contractions, which could benefit individuals with diarrhea-predominant IBS or other motility-related disorders. If confirmed in humans, FA-based interventions might offer a dietary or supplement option to help manage symptoms, reducing reliance on pharmaceuticals.
However, the effects might not be universally beneficial. For example, slowing gut movement could worsen constipation in some patients, emphasizing the need for personalized approaches. The research underscores the importance of further clinical testing before any recommendations can be made.
As an affiliate, we earn on qualifying purchases.
Background on Ferulic Acid and Gut Motility
Ferulic acid is a polyphenol abundant in whole grains, rice bran, and plant-based foods. It is known for its antioxidant and neuroprotective properties, with previous research focusing on its health benefits broadly. Its role in gastrointestinal function has been less studied until now.
The current research builds on earlier findings about gut muscle contractions and calcium signaling, aiming to identify natural compounds that could influence intestinal motility. Prior studies have explored various pharmacological agents, but dietary compounds like FA offer a potentially safer alternative if proven effective.
While animal studies have shown promising results, translating these findings to human health remains a key challenge. The research team emphasizes the need for clinical trials to evaluate safety, optimal dosing, and real-world effectiveness.
“Ferulic acid appears to inhibit calcium channels involved in muscle contraction, which could help regulate abnormal gut movements.”
— an anonymous researcher
As an affiliate, we earn on qualifying purchases.
Unconfirmed Effects in Humans and Practical Applications
It is not yet clear whether ferulic acid will have similar effects in humans as observed in laboratory experiments. The concentrations used in vitro exceed typical dietary intake, and the impact of supplementation or food-based consumption remains unknown. Human clinical trials are needed to establish safety, effective dosage, and actual therapeutic benefits.
As an affiliate, we earn on qualifying purchases.
Next Steps in Research and Clinical Trials
Researchers plan to conduct clinical trials to evaluate ferulic acid’s safety and efficacy in humans, particularly focusing on individuals with IBS and other motility disorders. These studies will help determine appropriate dosing, potential side effects, and whether FA can be integrated into dietary interventions or supplements.
calcium channel blocker supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Can eating rice bran or whole grains help with IBS symptoms?
While rice bran contains ferulic acid, current evidence does not confirm that dietary intake alone can significantly impact IBS symptoms. More research is needed to establish effective doses and benefits.
Is ferulic acid safe to take as a supplement for gut health?
Safety and efficacy of ferulic acid supplements for gut health are not yet established. Clinical trials are necessary before recommendations can be made.
Could ferulic acid worsen constipation in some people?
Yes, since it may slow intestinal contractions, ferulic acid could potentially exacerbate constipation in individuals with slow gut motility. Personalized medical advice is recommended.
When will human trials be conducted?
Researchers are planning to initiate clinical trials in the near future, but specific timelines have not yet been announced.
Does this mean rice bran could be used as a treatment?
Not yet. The current findings are preliminary and based on laboratory studies. Human research is essential before any therapeutic claims can be made.
Source: rss
